News
Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that obesity is a problem at all.
The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...
Following a freak accident, Scarlett Espinoza, 38, suffered a triple ankle fracture. To recover, she joined a workout ...
Are you a TRICARE beneficiary taking a drug for weight loss—such as a GLP-1 medication like Zepbound or Wegovy? Do you have ...
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
A sweeping analysis of global studies reveals that stopping weight loss drugs, including well-known treatments like Ozempic and Wegovy, often triggers a rapid return of lost pounds.
SHREVEPORT, La. - A new drug developed by Eli Lily works in a unique way compared to treatments already on the market, like ...
SHREVEPORT, La. - A new drug developed by Eli lily works in a unique way compared to treatments already on the market, like ...
What is being described as a groundbreaking discussion in the medical industry is linking hearing loss with dementia.
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...
Q2 2025 Earnings Call Transcript August 5, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $6.02, expectations ...
9d
Investor's Business Daily on MSNWhy S&P 500 Stock Amgen Stumbled Despite Its Beat-And-Raise Quarter
Amgen stock dropped Wednesday despite a strong second quarter as investors look ahead to the next weight-loss readouts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results